Welcome to our dedicated page for Agrify news (Ticker: AGFY), a resource for investors and traders seeking the latest updates and insights on Agrify stock.
The AGFY news page on Stock Titan aggregates company communications and regulatory disclosures related to Agrify Corporation, which SEC filings later identify as RYTHM, Inc., a business active in the cannabis and hemp industries. Press releases and filings trace the company’s evolution from a focus on cultivation and extraction technology toward branded hemp-derived THC beverages and cannabis brand intellectual property.
News items include quarterly and annual financial results, where Agrify reports revenue, operating losses, and cash balances, along with commentary on strategic priorities. Releases also cover financing events, such as a non-brokered private placement with institutional and accredited investors and secured convertible notes issued to a subsidiary of Green Thumb Industries Inc. and other investors, which the company describes as supporting working capital and business development.
Corporate updates highlight leadership and governance changes, including the appointment of a new Chairman and Interim Chief Executive Officer and additions to the Board of Directors. Transaction-focused announcements detail the acquisition of assets related to the Señorita hemp-derived THC beverage brand, the sale of the legacy cultivation business to an entity affiliated with a former executive, and the acquisition of intellectual property rights to brands such as RYTHM, Beboe, Dogwalkers, Doctor Solomon’s, &Shine, and Good Green.
Product and partnership news emphasizes the Señorita brand of hemp-derived THC beverages, including flavor launches and distribution through retailers in multiple U.S. states and Canada, as well as venue partnerships like the exclusive hemp-derived THC beverage arrangement at The Salt Shed music venue in Chicago. By reviewing this news stream, readers can follow how Agrify’s strategy, capital structure, and brand portfolio have been described over time in its own announcements and related filings.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Agrify Corporation (Nasdaq: AGFY) announced it will not proceed with the warrant inducement transaction initially proposed on April 19, 2023. The decision, influenced by stockholder interests and limitations on shelf registration, means Agrify will not receive the anticipated $1.84 million gross proceeds or issue approximately 21.3 million new warrants. The company confirmed that the lowered exercise price of previously issued warrants remains effective at $0.1725 per share. Agrify plans to explore alternative capital-raising strategies moving forward.
Agrify Corporation (Nasdaq: AGFY) announced on April 24, 2023, that it received a notification from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to the late filing of its Annual Report on Form 10-K for the fiscal year ending December 31, 2022. This notification does not immediately affect Agrify's stock listing, but failure to regain compliance may lead to potential delisting.
The company has 60 days to submit a compliance plan, with the deadline set for June 20, 2023. Agrify is currently addressing issues related to accounting errors that necessitate restating unaudited condensed consolidated financial statements from previous fiscal periods. The company aims to file its Form 10-K within this 60-day window to avoid further complications.
Agrify Corporation (Nasdaq: AGFY) announced on April 19, 2023, that it has entered into warrant inducement letters aiming to raise up to $1.84 million from the exercise of 10,651,430 common stock warrants. This follows a reduction in the exercise price from $0.65 to $0.1725 per share. The modified terms also include issuing new warrants to investors who exercise their existing warrants, allowing them to acquire additional shares at the reduced price. The warrant inducement period runs until April 21, 2023, with the potential to significantly increase funding for the company. The opportunity is designed to drive shareholder value while navigating the cannabis sector's evolving landscape.
Agrify Corporation (Nasdaq: AGFY) announced a significant milestone with the completion of Phase 1 of construction at the Denver Greens facility, which spans approximately 9,000 sq. ft. This facility will focus on cultivation and extraction in partnership with Denver Greens, pending regulatory approval. The project includes the deployment of 60 Vertical Farming Units (VFUs) for spring planting.
A distribution agreement with Kush Masters will enable the sale of VFU-grown cannabis products in around 350 Colorado dispensaries. Plans for Phase 2 aim to expand operations to incorporate extraction solutions, targeting SaaS revenue by Q3 2023 and production success fees in 2024.
The TTK Solution offers comprehensive support to cannabis operators, enhancing their production capabilities through innovative technologies.
Agrify Corporation (Nasdaq: AGFY) has completed construction on a cultivation facility for Nevada Holistic Medicine in Las Vegas, with flower production set to begin in April 2023. The facility will use 132 Vertical Farming Units (VFUs) to produce high-quality, medical-grade cannabis. Agrify anticipates generating high-margin recurring revenue streams from Software as a Service (SaaS) and production success fees starting in Q3 2023. The facility emphasizes providing medical-grade cannabis to local communities while enabling precise cultivation techniques.